We have commenced the post-listing review on spinal fusion cages listed on the Prescribed List (PL). The review will determine if the current benefits for integral fixation and no integral fixation devices reflect the clinical and cost effectiveness of these devices.
The review will explore the following questions:
- Does integral fixation, compared to no integral fixation, impact clinical outcomes?
- What mix of individual devices/components are used for integral fixation versus no integral fixation?
- Based on published cost-effectiveness studies, what is the comparative cost effectiveness of integral fixation compared to no integral fixation?
- Are the benefits and/or groupings of the devices appropriate?
The review will follow the process outlined in the post-listing review framework. We have engaged an external consultant to provide a report to inform the review.
Sponsors and relevant stakeholders have been notified and invited to submit relevant information to inform the external consultant review.
Stakeholders with additional information relevant to questions above, can provide us a submission via prescribedlist.reviews@health.gov.au by Monday 9 March 2026.
Updates on the progress of the review will be provided via the department’s website.